YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
42 hedge funds and large institutions have $176M invested in Y-mAbs Therapeutics in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
14% less capital invested
Capital invested by funds: $205M → $176M (-$29.7M)
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.05M | |
| 2 | +$6.65M | |
| 3 | +$4.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.5M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.59M |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$2.03M | |
| 3 | -$1.8M | |
| 4 |
Goldman Sachs
New York
|
-$1.49M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.33M |